Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine

Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chira...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 2010-09, Vol.99 (9), p.3931-3940
Hauptverfasser: Singh, Aniruddh, Myerson, Allan S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3940
container_issue 9
container_start_page 3931
container_title Journal of pharmaceutical sciences
container_volume 99
creator Singh, Aniruddh
Myerson, Allan S.
description Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used.
doi_str_mv 10.1002/jps.22237
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_748932954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915324965</els_id><sourcerecordid>748932954</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3867-96ef61c39859bfade79f464f84d03fe93c1d60880dae04591a06a7b03beb57273</originalsourceid><addsrcrecordid>eNp10MFu1DAQBmALgehSOPACyBeEOKR17DiOj6tVaanaglgoEhfLccbUxRsvnmzp8vQEsi0XmIsP882M_BPyvGQHJWP88HqNB5xzoR6QWSk5K2pWqodkNvZ4IWSl98gTxGvGWM2kfEz2OJNCSMln5MviKmQb6RKip3NEWLUROnqe-hTtFjJSi_QDYIo3of9K55vbEIPNAZCGng5XQBd5i4ONMfy0Q0g9TZ5e2hh6eEoeeRsRnu3effLpzdHHxUlx9u747WJ-VjjR1KrQNfi6dEI3UrfedqC0r-rKN1XHhActXNnVrGlYZ4FVUpeW1Va1TLTQSsWV2Cevpr3rnL5vAAezCuggRttD2qBRVaMF17Ia5etJupwQM3izzmFl89aUzPxO0oxJmj9JjvbFbuumXUF3L--iG8HLHbDobPTZ9i7gXyd42Yw1usPJ_QgRtv-_aE7fL-9OF9NEwAFu7yds_mZqJZQ0ny-OzYla6svTi8qcj15MHsaUbwJkgy5A76ALGdxguhT-8cFfB0mq_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748932954</pqid></control><display><type>article</type><title>Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Singh, Aniruddh ; Myerson, Allan S.</creator><creatorcontrib>Singh, Aniruddh ; Myerson, Allan S.</creatorcontrib><description>Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.22237</identifier><identifier>PMID: 20533552</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Hoboken: Elsevier Inc</publisher><subject>Acetylcysteine - chemistry ; Biological and medical sciences ; chirality ; crystal engineering ; crystal structure ; crystallization ; Crystallization - methods ; Cysteine - chemistry ; General pharmacology ; Glutathione - chemistry ; Gold - chemistry ; Medical sciences ; Penicillamine - chemistry ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; separation science ; Solubility ; Stereoisomerism ; Valine - chemistry</subject><ispartof>Journal of pharmaceutical sciences, 2010-09, Vol.99 (9), p.3931-3940</ispartof><rights>2010 Wiley-Liss, Inc.</rights><rights>Copyright © 2010 Wiley‐Liss, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3867-96ef61c39859bfade79f464f84d03fe93c1d60880dae04591a06a7b03beb57273</citedby><cites>FETCH-LOGICAL-c3867-96ef61c39859bfade79f464f84d03fe93c1d60880dae04591a06a7b03beb57273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.22237$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.22237$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23218888$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20533552$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh, Aniruddh</creatorcontrib><creatorcontrib>Myerson, Allan S.</creatorcontrib><title>Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used.</description><subject>Acetylcysteine - chemistry</subject><subject>Biological and medical sciences</subject><subject>chirality</subject><subject>crystal engineering</subject><subject>crystal structure</subject><subject>crystallization</subject><subject>Crystallization - methods</subject><subject>Cysteine - chemistry</subject><subject>General pharmacology</subject><subject>Glutathione - chemistry</subject><subject>Gold - chemistry</subject><subject>Medical sciences</subject><subject>Penicillamine - chemistry</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>separation science</subject><subject>Solubility</subject><subject>Stereoisomerism</subject><subject>Valine - chemistry</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MFu1DAQBmALgehSOPACyBeEOKR17DiOj6tVaanaglgoEhfLccbUxRsvnmzp8vQEsi0XmIsP882M_BPyvGQHJWP88HqNB5xzoR6QWSk5K2pWqodkNvZ4IWSl98gTxGvGWM2kfEz2OJNCSMln5MviKmQb6RKip3NEWLUROnqe-hTtFjJSi_QDYIo3of9K55vbEIPNAZCGng5XQBd5i4ONMfy0Q0g9TZ5e2hh6eEoeeRsRnu3effLpzdHHxUlx9u747WJ-VjjR1KrQNfi6dEI3UrfedqC0r-rKN1XHhActXNnVrGlYZ4FVUpeW1Va1TLTQSsWV2Cevpr3rnL5vAAezCuggRttD2qBRVaMF17Ia5etJupwQM3izzmFl89aUzPxO0oxJmj9JjvbFbuumXUF3L--iG8HLHbDobPTZ9i7gXyd42Yw1usPJ_QgRtv-_aE7fL-9OF9NEwAFu7yds_mZqJZQ0ny-OzYla6svTi8qcj15MHsaUbwJkgy5A76ALGdxguhT-8cFfB0mq_w</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>Singh, Aniruddh</creator><creator>Myerson, Allan S.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201009</creationdate><title>Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine</title><author>Singh, Aniruddh ; Myerson, Allan S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3867-96ef61c39859bfade79f464f84d03fe93c1d60880dae04591a06a7b03beb57273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acetylcysteine - chemistry</topic><topic>Biological and medical sciences</topic><topic>chirality</topic><topic>crystal engineering</topic><topic>crystal structure</topic><topic>crystallization</topic><topic>Crystallization - methods</topic><topic>Cysteine - chemistry</topic><topic>General pharmacology</topic><topic>Glutathione - chemistry</topic><topic>Gold - chemistry</topic><topic>Medical sciences</topic><topic>Penicillamine - chemistry</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>separation science</topic><topic>Solubility</topic><topic>Stereoisomerism</topic><topic>Valine - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Aniruddh</creatorcontrib><creatorcontrib>Myerson, Allan S.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Aniruddh</au><au>Myerson, Allan S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2010-09</date><risdate>2010</risdate><volume>99</volume><issue>9</issue><spage>3931</spage><epage>3940</epage><pages>3931-3940</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution ofracemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used.</abstract><cop>Hoboken</cop><pub>Elsevier Inc</pub><pmid>20533552</pmid><doi>10.1002/jps.22237</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 2010-09, Vol.99 (9), p.3931-3940
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_748932954
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Acetylcysteine - chemistry
Biological and medical sciences
chirality
crystal engineering
crystal structure
crystallization
Crystallization - methods
Cysteine - chemistry
General pharmacology
Glutathione - chemistry
Gold - chemistry
Medical sciences
Penicillamine - chemistry
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
separation science
Solubility
Stereoisomerism
Valine - chemistry
title Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A37%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chiral%20Self%20Assembled%20Monolayers%20as%20Resolving%20Auxiliaries%20in%20the%20Crystallization%20of%20Valine&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Singh,%20Aniruddh&rft.date=2010-09&rft.volume=99&rft.issue=9&rft.spage=3931&rft.epage=3940&rft.pages=3931-3940&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.22237&rft_dat=%3Cproquest_cross%3E748932954%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=748932954&rft_id=info:pmid/20533552&rft_els_id=S0022354915324965&rfr_iscdi=true